Assembly Biosciences, Inc.
ASMB
$32.87
-$2.41-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 62.84% | -80.66% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 62.84% | -80.66% | |||
| Cost of Revenue | 0.11% | -13.62% | |||
| Gross Profit | 76.93% | -126.52% | |||
| SG&A Expenses | 2.52% | -13.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.69% | -13.62% | |||
| Operating Income | 44.20% | -157.43% | |||
| Income Before Tax | 57.52% | -141.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 57.52% | -141.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 57.52% | -141.10% | |||
| EBIT | 44.20% | -157.43% | |||
| EBITDA | 44.25% | -157.20% | |||
| EPS Basic | 61.91% | -141.19% | |||
| Normalized Basic EPS | 61.91% | -141.20% | |||
| EPS Diluted | 61.91% | -141.19% | |||
| Normalized Diluted EPS | 61.91% | -141.20% | |||
| Average Basic Shares Outstanding | 11.56% | -0.23% | |||
| Average Diluted Shares Outstanding | 11.56% | -0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||